Advertisement

J&J Philippines supports employees who want to quit smoking during lockdown

As Filipinos continue to adjust to the changing situations under community quarantine due to the COVID-19 pandemic, Johnson & Johnson (Philippines), Inc. (J&J Philippines) is extending support to its employees who wish to quit smoking for good.

J&J employees take on the challenge to quitting smoking with their Nicotine Polacrilex (Nicorette) 2mg Medicated Chewing Gum Menthol Mint and Quit Guide 1
The program, which is part of the brand's Operation Quit global campaign, is the latest of many wellness programs made available by the company to ensure the health and wellbeing of its workforce.

Over a 12-week period, interested participants will be supplied with packs of Nicotine Polacrilex (Nicorette) 2mg Medicated Chewing Gum, J&J’s Nicotine Replacement Therapy (NRT) product, along with a Quitting Booklet and motivational materials to assist them in their journey to stop smoking.

Nicotine Polacrilex (Nicorette) is designed to help willing smokers manage their cravings and withdrawal symptoms while on the road to quitting smoking for good.

The initiative was extended to all 1,500 employees of J&J Philippines as well as their friends and families via a sign up form on the Nicorette Philippines website. 

Program participants received Nicotine Polacrilex (Nicorette) 2mg Medicated Chewing Gum Menthol Mint and a quit smoking guide delivered straight to their homes.
“As a company, we are committed to the health and well-being of our employees, especially during these difficult and uncertain times,” J&J Philippines Director for Human Resources and Corporate Contributions Sean Zantua said. 

“For us, this program aims to inspire and motivate those within our network to continue on in their quitting journey, and to assure them that they are supported," he said.

J&J Philippines Managing Director Raghu Krishnan added: “Our expertise in smoking cessation globally has shown us that quitting smoking is different for each person. With this program, we wanted to ensure that our employees and their families have the assistance they need in order to quit smoking more effectively.”

Nicotine Polacrilex (Nicorette) is a product under J&J Philippines’ consumer health portfolio and will be made available to Filipino consumers in select retail stores by September 2020.

To know more about Nicotine Polacrilex (Nicorette) in the Philippines, you may visit www.nicorette.com.ph.

Topics: Johnson & Johnson Philippines Inc , J&J’s Nicotine Replacement Therapy , COVID-19 , Nicotine Polacrilex , Raghu Krishnan
COMMENT DISCLAIMER: Reader comments posted on this Web site are not in any way endorsed by Manila Standard. Comments are views by manilastandard.net readers who exercise their right to free expression and they do not necessarily represent or reflect the position or viewpoint of manilastandard.net. While reserving this publication’s right to delete comments that are deemed offensive, indecent or inconsistent with Manila Standard editorial standards, Manila Standard may not be held liable for any false information posted by readers in this comments section.
AdvertisementSpeaker GMA
Advertisement